Featured
On the edge: Here comes the $550B cliff
An industry-wide, monster patent cliff fall will hit pharma in the next four years and even one of the world's newest blockbusters is not safe
Jobs & Workplace
Open: Netflix-style library for Medical Affairs
The new resource is a living, curated repository bringing the growing evidence base around the medical affairs function together in one place - and its free
Industry & Companies
Pharma backs Australia’s World Cup campaign
A company has announced its sponsorship of the Poweroos, saying the partnership reflects a broader commitment to supporting people living with rare and neuromuscular conditions
Regulation & Legal
Which specialists are embracing AI?
A survey including Australian doctors has revealed which HCPs have the highest trust in AI tools - and which specialties are not AI fans as the TGA investigates regulations in the space
Regulatory & Reimbursement
Call for accelerated rare cancers pathway
Rare Cancers Australia is calling for a raft of reforms, including reducing the median time from TGA approval of a medicine to PBS listing from 639 days to just 60
Leadership & People
Butler sidesteps 'future PM' speculation
Minister deftly sidesteps questions about growing speculation he is the Labor Party's "leader-in-waiting" when Anthony Albanese's time as PM comes to an end
Industry & Companies
GM says Australia cannot afford to fall behind
The BMS Patient & Parliament Summit will be held in Canberra today with urgent action needed for patients who fear they won't survive the wait for treatment
Regulatory & Reimbursement
PBS election sweetener pays off for voters
New figures released by the Department of Health shows more than one million women have accessed newly PBS listed medicines since March 2025
Featured
Patients pick best pharma but there's a problem
When it comes to favourite pharmas, one company is a clear standout according to this patient cohort which says industry's overall corporate reputation has improved... except in one crucial area
Jobs & Workplace
Redundancies hit pharma spin-off
Jobs have been cut following a recent field force review with changes made to ensure the company's customer coverage model reflects an evolving market
Regulatory & Reimbursement
Medicine moves to OTC to ease access issues
A previously prescription-only drug has hit the shelves as a pharmacy drug, with the hope it will increase awareness of the ability to treat symptoms
Regulatory & Reimbursement
Company takes second tilt at a PBAC 'Yes'
The agenda for the November PBAC meeting has been updated with one company rejected in July making quick work of trying again
Featured
Pharma promotes exec to Country Lead
High-flyer has been promoted to Country Lead, taking responsibility for heading the company's innovative medicines business in Australia
Regulatory & Reimbursement
TGA approval lands in the nick of time
A new asthma treatment set to be considered for PBS funding at the PBAC's intracycle meeting this month has been approved for use in Australia
Jobs & Workplace
Pharma bosses call out work-life balance
Two senior pharma executives - one a former Aussie GM - have called out perfect work-life balance as an unrealistic expectation placed on the industry
Regulatory & Reimbursement
Double or nothing: Unlocking access to new drugs
Medicines Australia has outlined an ambitious plan for the Government to double its spending on innovative medicines
Regulatory & Reimbursement
This drug won a standing ovation but will Aussies ever see it?
A breakthrough drug for pancreatic cancer was given a standing ovation at ASCO this year but for Australian patients there's likely a long wait ahead
Jobs
-
Account Manager New
-
Regulatory and Quality Manager New
-
Regulatory Affairs Manager New
-
Director, Business Development - Clinical Research (Tokyo Based) New
-
Medical Science Liaison New
-
Clinical Project Manager New
-
Technical Customer Service Representative New
-
Technical Customer Service Representative New
-
Hospital Specialist Representative New
-
Hospital Specialist Representative New
Jobs & Workplace
Sydney exec lands GM role overseas
Stepping up from a Business Unit Director role, this executive has packed her bags and made the move to Bulgaria, to take on the position of General Manager at a Big Pharma
Regulatory & Reimbursement
Another domino falls for drug in TGA probe
With another jurisdiction revoking approval, it's not looking good for a drug that has been linked to eight deaths overseas that is being reviewed by the TGA.
Industry & Companies
ACCC approves $68 billion acquisition
The ACCC has given the go-ahead for the merger of a Johnson & Johnson spin-out with another mega company... but on one condition
Latest
Does Aussie pharma pass the Pub Test?
Companies have been urged to apply the "PUB Test" to upcoming initiatives designed to engage HCPs - before they go to market - otherwise they risk missing the mark
Jobs & Workplace
Who's cracked America’s Best Companies list?
Despite the overall trend of tech dominance in the US, two pharmaceutical companies have broken into TIME’s Top 10 list of America’s Best Companies for 2026.
Regulatory & Reimbursement
BMS notches a first with TGA tick
Once-daily pill, the first treatment of its kind to be registered in Australia for a debilitating condition, marks an 'important milestone' for patients
- Jobs & Workplace Big Pharma picks Sydney CBD for new HQ
- Leadership & People Who’s up for a 2026 PRIME Award?
- Industry & Companies Pharma rejoins Medicines Australia
- Regulatory & Reimbursement The secrecy that hampers PBAC decisions
- Industry & Companies Pharma deal to ramp up retail reach in Australia
- Regulatory & Reimbursement CSL lowers prices in Trump MFN deal
- Industry & Companies What's the Govt's ROI on mRNA initiatives?
- Industry & Companies Who has the most effective MSLs, and why?
- Regulatory & Reimbursement CEO raises red flag on PBS transparency
- Regulatory & Reimbursement World's biggest drug wins broad PBS listing
